REGADENOSON .08 mg/mL
REGADENOSON · INJECTION, SOLUTION · Accord Healthcare Inc.
Regadenoson is an injectable medication given through a vein that is used during heart stress tests to help doctors see how your heart responds to increased blood flow. It works by temporarily widening blood vessels to simulate the effects of exercise on the heart.
Key Facts
- Brand Name
- REGADENOSON
- Generic Name
- REGADENOSON
- NDC Code (Product)
16729-477- Manufacturer
- Accord Healthcare Inc.
- Strength
- .08 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA213236
- Marketing Start
- 03/10/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is REGADENOSON used for?
Regadenoson is an injectable medication given through a vein that is used during heart stress tests to help doctors see how your heart responds to increased blood flow. It works by temporarily widening blood vessels to simulate the effects of exercise on the heart.
Is REGADENOSON a controlled substance?
REGADENOSON is not classified as a controlled substance by the DEA.
What is the generic name for REGADENOSON?
The generic name for REGADENOSON is REGADENOSON. There are 11 other brand versions of REGADENOSON.
What is the NDC code for REGADENOSON .08 mg/mL?
The NDC (National Drug Code) for REGADENOSON .08 mg/mL is 16729-477, listed by Accord Healthcare Inc..